title: A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases.
abstract: OBJECTIVE
  To report the clinicopathological findings of 21 cases of primary nodal marginal zone B-cell lymphoma (NMZL). NMZL is a recently characterized lymphoma and few series have been published.
  
  
  RESULTS
  The clinical data were characteristic of a disseminated disease at presentation: presence of peripheral and abdominal lymph nodes, bone marrow involvement (62%), disease stage III and IV (76%), elevated lactate dehydrogenase (LDH) (48%). Other features included peripheral blood involvement (23%), anaemia (24%), thrombocytopenia (10%) and presence of serum M component (33%), while the previously reported association with hepatitis C virus and cryoglobulinaemia was not found. Relapses were frequent but the majority of patients receiving chemotherapy had a good initial response. Morphological features were heterogeneous and there were some differences compared with other marginal zone B-cell lymphomas (MZL). Pure monocytoid B-cell lymphomas were rare (10%) but a minor component of monocytoid B cell was observed more frequently (23%). Plasmacytoid or plasmacytic differentiation was a very common feature (61%). Large cells and a high mitotic count were also frequent (57%).
  
  
  CONCLUSIONS
  NMZL can be distinguished from splenic MZL and extranodal MZL by its aggressive morphology and disseminated disease at presentation.
authors.affiliation: Service d'Anatomie Pathologique, Centre Hospitalier Lyon Sud, Pierre Benite, Lyon, France.
authors.forename: A
authors.initials: A
authors.lastname: Traverse-Glehen
authors.forename: P
authors.initials: P
authors.lastname: Felman
authors.forename: E
authors.initials: E
authors.lastname: Callet-Bauchu
authors.forename: S
authors.initials: S
authors.lastname: Gazzo
authors.forename: L
authors.initials: L
authors.lastname: Baseggio
authors.forename: P A
authors.initials: PA
authors.lastname: Bryon
authors.forename: C
authors.initials: C
authors.lastname: Thieblemont
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
authors.forename: G
authors.initials: G
authors.lastname: Salles
authors.forename: F
authors.initials: F
authors.lastname: Berger
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018951:Antigens, CD20 / Q000032:analysis; D001853:Bone Marrow / Q000473:pathology; D004268:DNA-Binding Proteins / Q000032:analysis; D005260:Female; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D007621:Karyotyping; D008198:Lymph Nodes / Q000473:pathology; D016393:Lymphoma, B-Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D051560:Proto-Oncogene Proteins c-bcl-6; D016019:Survival Analysis; D014178:Translocation, Genetic
chemical_list: D018951:Antigens, CD20; C084103:BCL6 protein, human; D004268:DNA-Binding Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D051560:Proto-Oncogene Proteins c-bcl-6